Trials / Conditions / Thyroid Gland Squamous Cell Carcinoma
Thyroid Gland Squamous Cell Carcinoma
4 registered clinical trials studyying Thyroid Gland Squamous Cell Carcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Lenvatinib and Pembrolizumab for the Treatment of Stage IVB Locally Advanced and Unresectable or Stage IVC Met NCT04171622 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | Pembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF-Mutated Anaplastic Thyroid NCT04675710 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer NCT04759911 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Ca NCT03449108 | M.D. Anderson Cancer Center | Phase 2 |